BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Best Practices in Establishing a Telemedicine Practice in Neuromuscular Disease

Activity Snapshot

Activity Type: 
Live, Virtual Webinar
Release Date: 
Tuesday, May 19, 2020

Faculty

Catherine Lomen-Hoerth MD, PhD
Catherine Lomen-Hoerth MD, PhD
Director, ALS Center
UC San Francisco Medical Center
Alison Scheid PT, DPT, OCS, NCS
Alison Scheid PT, DPT, OCS, NCS
Program Director, Orthopedic Physical Therapy Residency Program
UC San Francisco
Eve Cohen, RN
Eve Cohen, RN
Nurse Program Manager, Palliative Care Clinic
UC San Francisco
Lauren Dunne, BSRT, RRT-ACCS
Lauren Dunne, BSRT, RRT-ACCS
ALS Treatment & Research Center, UC San Francisco
Hannah George, MS
Hannah George, MS
Clinical Research Coordinator, ALS Clinic and Parkinson's Center
UC San Francisco
Best Practices in Establishing a Telemedicine Practice in Neuromuscular Disease
Activity Overview: 

In this webinar, the team from the MDA Care Center at UC San Francisco Medical Center discuss their experience with establishing a multidisciplinary telehealth practice. The panelists discuss their history with telemedicine, how they overcame obstacles to establish their practice, best practices for adapting PT and respiratory assessments for a virtual visit, and how the current public health emergency is changing telemedicine.

Learning Objectives: 

The panelists discuss their experiences with telemedicine. Topics included in this roundtable discussion are:

  • Panelist’s history with telemedicine
  • Strategies for overcoming obstacles
  • Scheduling and clinic workflow
  • Adapting physical and respiratory therapy assessments for a virtual visits
  • Ways the COVID-19 public health emergency is changing telemedicine

Copyright 2021 Muscular Dystrophy Association. All rights reserved. The Medical Education Program(s) in their entirety (including, but not limited to: webinar(s), speaker deck presentation(s), MDA Monthly Report content and case studies) are owned by Muscular Dystrophy Association and the associated partner(s) and may not be copied, reproduced, or altered in any manner without MDA’s prior written consent except that the User(s) may download, view, or use these program(s) for educational purposes only.

The Terms of Use permit User(s) to use the Medical Education Program(s) for personal and/or public education only. A User may download the information to share but will not be permitted to alter the information in any way. The User(s) is permitted to educate on one or all sections of the program(s). Any appropriate use of content available from the Medical Education Program(s) must not remove any trademarks, copyright, or any other notice contained in such content.

If you wish to alter any of the Medical Education Program(s) presented by the MDA in a form other than what is set out on mda.org, please consult meded@mdausa.org.